Abstract
The reported number of transcatheter aortic valve replacement-associated infective endocarditis (TAVR-IE) cases has been increasing worldwide, but information about the incidence and clinical features of fungal TAVR-IE is quite limited. We present a patient who acquired TAVR-IE caused by Candida parapsilosis four month after TAVR, who was successfully treated redo-aortic valve replacement and prolonged antifungal therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 215-217 |
| Number of pages | 3 |
| Journal | Journal of Infection and Chemotherapy |
| Volume | 25 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 03-2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Pharmacology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Fungal endocarditis after transcatheter aortic valve replacement (TAVR): Case report and review of literature'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver